supplier qualification – Page 14

Sampling plan not risk-based during deviation investigation – CAPA to prevent recurrence

Deviations Due to Non-Risk-Based Sampling Plans: Investigating the Root Causes and CAPAs Deviations in pharmaceutical manufacturing often arise from inadequate sampling plans that fail to consider risk factors, leading to…

Sampler training deficiency during incoming material receipt – CAPA to prevent recurrence

Addressing Deficiencies in Sampler Training During Incoming Material Receipt Deficiencies in sampler training during the receipt of incoming materials can lead to significant quality risks in pharmaceutical manufacturing. These risks…

Improper sample storage during incoming material receipt – inspection-ready sampling justification

Investigating Improper Sample Storage During Incoming Material Receipt Improper sample storage during the receipt of incoming materials can lead to non-compliant conditions and subsequent quality failures in pharmaceutical manufacturing. Addressing…

Sampling SOP not followed during internal audit – GMP expectations for material sampling

Investigating Non-Compliance with Internal Audit SOPs for Material Sampling In the realm of pharmaceutical manufacturing, adherence to standard operating procedures (SOPs) is non-negotiable, particularly during internal audits. A scenario that…

Vendor change implemented without approval during routine supplier audit – supplier risk classification strategy

Unauthorized Vendor Change Noted During Routine Supplier Audit: An Investigation Framework In the pharmaceutical manufacturing environment, adherence to protocols during vendor change management is crucial to maintaining product integrity and…

Critical supplier risk not assessed during routine supplier audit – supplier risk classification strategy

Unveiling Critical Supplier Risk Assessment Gaps During Routine Audits In the world of pharmaceutical manufacturing, the integrity of raw materials is paramount. When critical supplier risks are overlooked during routine…

Supplier audit findings escalated during requalification – inspection questions regulators ask

Investigating Supplier Audit Findings During Requalification: A Guide for Pharma Professionals In the highly regulated pharmaceutical industry, ensuring that supplier audit findings are swiftly and effectively addressed is critical for…

Inadequate vendor qualification during regulatory inspection – supplier risk classification strategy

Inadequate Vendor Qualification Revealed During Regulatory Inspection: A Pragmatic Investigation Approach In the recent past, multiple pharmaceutical manufacturers faced challenges stemming from inadequate vendor qualifications. These challenges, often revealed during…

Tag: supplier qualification

Sampling plan not risk-based during deviation investigation – CAPA to prevent recurrence

Sampler training deficiency during incoming material receipt – CAPA to prevent recurrence

Improper sample storage during incoming material receipt – inspection-ready sampling justification

Sampling SOP not followed during internal audit – GMP expectations for material sampling

Vendor change implemented without approval during routine supplier audit – supplier risk classification strategy

Critical supplier risk not assessed during routine supplier audit – supplier risk classification strategy

Supplier audit findings escalated during requalification – inspection questions regulators ask

Inadequate vendor qualification during regulatory inspection – supplier risk classification strategy

Critical supplier risk not assessed during supplier onboarding – evidence pack for vendor oversight

Supplier audit findings escalated during routine supplier audit – how to prevent repeat supplier failures

Critical supplier risk not assessed during supplier onboarding – supplier risk classification strategy

Vendor change implemented without approval during supplier onboarding – inspection questions regulators ask